| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 04/26/2001 | WO2001028559A1 Method for stabilizing benzimidazole compounds |
| 04/26/2001 | WO2001028558A1 Formulation of substituted benzimidazoles |
| 04/26/2001 | WO2001028556A2 Compositions for prevention and treatment of cold and influenza-like symptoms and their methods of use |
| 04/26/2001 | WO2001028555A1 Emulsion compositions for polyfunctional active ingredients |
| 04/26/2001 | WO2001028552A2 Antimicrobial compositions comprising pyroglutamic acid and optionally metal salts |
| 04/26/2001 | WO2001028544A2 Dialysis solution including polyglycol osmotic agent |
| 04/26/2001 | WO2001028538A2 Laxative preparation containing l-arginine |
| 04/26/2001 | WO2001028535A2 Pharmaceutical formulations comprising a combination of s-salmeterol and fluticasone propionate |
| 04/26/2001 | WO2001028531A1 Transdermal therapeutic system containing tulobuterol hydrochloride for administering the bronchodilator tulobuterol via the skin |
| 04/26/2001 | WO2001028530A1 Microcapsules for stabilizing cosmetic, pharmaceutical or food products |
| 04/26/2001 | WO2001028529A1 Pharmaceutical products and methods of fabrication therefor |
| 04/26/2001 | WO2001028528A1 Methods, pharmaceutical and therapeutic compositions for administering adenosine |
| 04/26/2001 | WO2001028527A2 Direct compression polymer tablet core |
| 04/26/2001 | WO2001028526A2 Gastroresistant tablets for alimentary, dietetic and therapeutic use |
| 04/26/2001 | WO2001028525A2 Method of producing sub-micron particles of biologically active agents |
| 04/26/2001 | WO2001028524A1 Sustained release microspheres |
| 04/26/2001 | WO2001028523A1 Powder pharmaceutical formulations |
| 04/26/2001 | WO2001028522A2 Method for producing liposome preparation |
| 04/26/2001 | WO2001028521A2 Liposome formulation of 6,9-bis-[(2-aminoethyl)-amino]benzo[g]isoquinoline-5,10-dione dimaleate |
| 04/26/2001 | WO2001028520A1 Microemulsion preconcentrates, microemulsion and use of such a composition |
| 04/26/2001 | WO2001028519A1 Microemulsion preconcentrates and microemulsions |
| 04/26/2001 | WO2001028518A1 Microemulsion preconcentrates which contain cyclosporines and corresponding microemulsions |
| 04/26/2001 | WO2001028517A1 Aqueous medicinal compositions |
| 04/26/2001 | WO2001028516A2 Sustained-release formulations for treating cns-mediated disorders |
| 04/26/2001 | WO2001028515A1 Pharmaceutical composition for treatment of mucosal epithelial ulceration and/or erosion |
| 04/26/2001 | WO2001028514A1 Pharmaceutical aerosol formulations comprising s-salmeterol |
| 04/26/2001 | WO2001028511A2 Selective removal of contaminants from a surface using magnets |
| 04/26/2001 | WO2001028492A2 Polyanhydrides with biologically active degradation products |
| 04/26/2001 | WO2001028491A2 Method and composition for the treatment of dermatologic diseases |
| 04/26/2001 | WO2001028474A1 Ophthalmic drug delivery device |
| 04/26/2001 | WO2001028472A1 Drug delivery device |
| 04/26/2001 | WO2001028363A1 Method for treatment of chronic venous insufficiencies using an extract of red vine leaves |
| 04/26/2001 | WO2001028356A2 Food supplement for increasing lean mass and strength |
| 04/26/2001 | WO2001028336A1 A topical, non-cytotoxic, antimicrobial hydrogel with thixotropic properties |
| 04/26/2001 | WO2001003645A3 Methods and apparatus for relieving headaches, rhinitis and other common ailments |
| 04/26/2001 | WO2000071153A3 Medicament for localised application, containing fibrinogen, thrombin, transglutaminases and proteinase inhibitors |
| 04/26/2001 | WO2000069415A3 Melt granulation |
| 04/26/2001 | WO2000059447A3 Use of sex hormones to obtain a nasal pharmaceutical composition that is useful in the treatment of undesirable uterine bleeding |
| 04/26/2001 | WO2000057869A3 Viral treatment |
| 04/26/2001 | WO1997035591B1 Method of treating ciliary dyskinesia with uridine triphosphates and related compounds |
| 04/26/2001 | WO1997034932A3 Compositions containing starch excipients |
| 04/26/2001 | US20010000510 Electrostatic bonding type macromolecular micelle drug carrier and carried thereon |
| 04/26/2001 | US20010000471 Active medicament such as dimenhydrinate, an inner oil substance coating of given melting point, such as soybean oil, and outer coating layer of a polymeric substance such as ethyl cellulose; free of bad tastes |
| 04/26/2001 | US20010000470 Matrix of a biocompatible polymer and a drug, having a hydrophobic or amphiphilic compound to modify the diffusion of water into the matrix and the release of the drug; prolongs degradation of hydrolytically unstable polymers |
| 04/26/2001 | DE19950066A1 Transdermal therapeutic system based on polyacrylate matrix carrier comprises tulobuterol hydrochloride |
| 04/26/2001 | DE19949253A1 Vorrichtung zur Herstellung naßkaschierter Mehrschicht-Laminate An apparatus for producing multi-layer laminates naßkaschierter |
| 04/26/2001 | DE19949252A1 Superfizielles therapeutisches System zur topischen Applikation von Acetylsalicylsäure zur Behandlung von Akne-Erkrankungen Superficial therapeutic system for the topical application of acetylsalicylic acid for the treatment of acne diseases |
| 04/26/2001 | DE19946822A1 Wirk- und/oder Hilfsstoffe enthaltende Zubereitung mit steuerbarer Freisetzung dieser Stoffe, sowie ihre Verwendung und Herstellung Active and / or adjuvants containing preparation with controllable release of these substances, and their use and production |
| 04/26/2001 | DE19938825A1 Wirkstoffkombination mit Clonidin Drug combination with clonidine |
| 04/26/2001 | CA2388653A1 Method of producing sub-micron particles of biologically active agents |
| 04/26/2001 | CA2388166A1 Microcapsules for stabilizing cosmetic, pharmaceutical or food products |
| 04/26/2001 | CA2387925A1 Magnetic targeted carrier composed of iron and porous materials for the targeted delivery of biologically active agents |
| 04/26/2001 | CA2387819A1 Sustained-release formulations for treating cns-mediated disorders |
| 04/26/2001 | CA2387580A1 Synthetic substrate for tissue formation |
| 04/26/2001 | CA2387558A1 Polyanhydrides with biologically active degradation products |
| 04/26/2001 | CA2387511A1 Protein-containing granules and granule formulations |
| 04/26/2001 | CA2386422A1 Pharmaceutical composition for treatment of mucosal epithelial ulceration and/or erosion |
| 04/26/2001 | CA2386408A1 Formulations of hyaluronic acid for delivery of osteogenic proteins |
| 04/26/2001 | CA2386155A1 Method for producing liposome preparation |
| 04/26/2001 | CA2386143A1 Liposome formulation of 6,9-bis-[(2-aminoethyl)-amino]benzo[g]isoquinoline-5,10-dione dimaleate |
| 04/26/2001 | CA2382985A1 Antimicrobial compositions comprising pyroglutamic acid and optionally metal salts |
| 04/26/2001 | CA2382978A1 Powder pharmaceutical formulations |
| 04/26/2001 | CA2382864A1 Dialysis solution including polyglycol osmotic agent |
| 04/26/2001 | CA2356177A1 Aqueous pharmaceutical compositions |
| 04/25/2001 | EP1094073A2 Analogs of PTH and PTHRP, their synthesis and use for the treatment of osteoporosis |
| 04/25/2001 | EP1093819A2 Compounds and compositions for delivering active agents |
| 04/25/2001 | EP1093818A1 Powdery preparation for mucosal administration containing polymeric medicine |
| 04/25/2001 | EP1093816A2 Use of ST1435 in hormonal therapy by transdermal application |
| 04/25/2001 | EP1093815A1 Oral 2-methyl-thieno-benzodiazepine formulation |
| 04/25/2001 | EP1093813A2 Process for preparing polymer coated tablet comprising amoxycillin and clavunalate, coated with an aqueous polymeric filmcoating |
| 04/25/2001 | EP1093810A1 Fast-dissolving tablet comprising brotizolam |
| 04/25/2001 | EP1093374A1 Hypo-osmotic saline solutions, method for preparing same and medicines based on said solutions |
| 04/25/2001 | EP1093363A1 Methods and compositions for treatment of disorders associated with chlamydial and similar bacterial infection |
| 04/25/2001 | EP1093361A1 Plaster which contains steroids, and a method for the production and use thereof |
| 04/25/2001 | EP1093348A1 Methods and transdermal compositions for pain relief |
| 04/25/2001 | EP1007068A4 Process for preparing synthetic soil-extract materials and medicaments based thereon |
| 04/25/2001 | EP0804176B1 Transdermal presentation of nitroglycerin for preventing undesired labour |
| 04/25/2001 | EP0626863B1 Formulations containing hyaluronic acid |
| 04/25/2001 | CN1292816A Encapsulation of living tissue cells in microsphere |
| 04/25/2001 | CN1292795A Certain dinucleotides and their use as membrana mucosa cilium clearing and cilium vibration frequency regulating agent |
| 04/25/2001 | CN1292714A Aerosolized active agent delivery |
| 04/25/2001 | CN1292707A Anhydrous topical skin preparation |
| 04/25/2001 | CN1292703A Bubbling enteric coated preparations |
| 04/25/2001 | CN1292701A Glucocorticoid receptor antagonists for treatment of dementia |
| 04/25/2001 | CN1292696A Composition |
| 04/25/2001 | CN1292692A Oral preparations containing forskolin derivatives and process for producing medicinal preparations |
| 04/25/2001 | CN1292691A Preparation for treatment of erectile dysfunction |
| 04/25/2001 | CN1292689A Fat emulsions for inhalational administration |
| 04/25/2001 | CN1292688A Methods and compositions for detection and diagnosis of infectious diseases |
| 04/25/2001 | CN1292687A Nonoparticles, method for producing nanoparticles and use of the same |
| 04/25/2001 | CN1292686A Delivery system to modulate immune response |
| 04/25/2001 | CN1292684A Emulsion preconcentrate containing cyclosporin or macrolide |
| 04/25/2001 | CN1292683A Compositions containing organic compounds |
| 04/25/2001 | CN1292641A Tissue paper having antimicrobial skin lotion |
| 04/25/2001 | CN1292293A Infantile hernia truss and its making method |
| 04/25/2001 | CN1292286A Medicine preparation containing cotton rose leaf extract |
| 04/25/2001 | CN1292277A Medicine for curing chicken disease of respiratory tract |
| 04/25/2001 | CN1292264A Phosphodiesterase inhibitor and its use |
| 04/25/2001 | CN1292262A 15-40% acetaminophen solution preparation |
| 04/25/2001 | CN1292261A Plant hard capsule and its production process |